(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.41%) $78.43
(1.54%) $2.18
(0.08%) $2 310.50
(0.41%) $26.80
(0.13%) $966.60
(-0.36%) $0.929
(-1.19%) $10.86
(-0.12%) $0.797
(0.52%) $91.61
-0.14% KRW 71 900
Live Chart Being Loaded With Signals
Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally...
Stats | |
---|---|
Volumen de hoy | 151 677 |
Volumen promedio | 510 301 |
Capitalización de mercado | 5 285.46B |
EPS | KRW0 ( 2024-04-30 ) |
Próxima fecha de ganancias | ( KRW355.99 ) 2024-07-26 |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW99.33 (0.14%) |
Volumen Correlación
Yuhan Corporation Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Yuhan Corporation Correlación - Moneda/Commodity
Yuhan Corporation Finanzas
Annual | 2023 |
Ingresos: | KRW1 858.98B |
Beneficio Bruto: | KRW595.83B (32.05 %) |
EPS: | KRW1 815.36 |
FY | 2023 |
Ingresos: | KRW1 858.98B |
Beneficio Bruto: | KRW595.83B (32.05 %) |
EPS: | KRW1 815.36 |
FY | 2022 |
Ingresos: | KRW1 775.85B |
Beneficio Bruto: | KRW518.20B (29.18 %) |
EPS: | KRW1 265.47 |
FY | 2021 |
Ingresos: | KRW1 687.81B |
Beneficio Bruto: | KRW524.65B (31.08 %) |
EPS: | KRW1 595.92 |
Financial Reports:
No articles found.
Yuhan Corporation
Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal injury; ETC products in the areas of cardiovascular, alimentary, genito-urinary, metabolic, respiratory and allergy, and neuro systems; anti-infective, anti-cancer, and hormone and other products; and analgesics, anti-rheumatics, and anesthetics. It also offers OTC products, including vitamins and minerals, hepatopathy drugs and tonics, respiratory system drugs, alimentary system drugs, dermatology and analgesics drugs, and others; and household and healthcare products, such as bleaches, detergents, pesticides, and oral care products. In addition, the company engages in dental business and offers implants, dental equipment/consumable, and dental care products. Additionally, the company manufactures and sells medical supplies for livestock, aquatic animals, and household pets. Further, it provides contract manufacturing services. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico